tiprankstipranks
Trending News
More News >
NervGen Pharma (NGENF)
OTHER OTC:NGENF
US Market
Advertisement

NervGen Pharma (NGENF) Technical Analysis

Compare
77 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
3Neutral
5Bearish
Technical Analysis Consensus
Sell
3Bullish
3Neutral
4Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
NervGen Pharma’s (NGENF) Moving Averages Convergence Divergence (MACD) indicator is 0.43, suggesting NervGen Pharma is a Sell.
NervGen Pharma’s (NGENF) 20-Day exponential moving average is 3.36, while NervGen Pharma’s (NGENF) share price is $4.15, making it a Buy.
NervGen Pharma’s (NGENF) 50-Day exponential moving average is 2.99, while NervGen Pharma’s (NGENF) share price is $4.15, making it a Buy.

NervGen Pharma (NGENF) Pivot Points

Dec 06, 2025, 02:11 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.59
3.87
4.14
4.42
4.69
4.97
5.24
Fibonacci
3.87
4.08
4.21
4.42
4.63
4.76
4.97
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

NervGen Pharma (NGENF) Moving Averages

Dec 06, 2025, 02:11 AM
Period
Simple
Exponential
MA5
4.24Sell
4.11Buy
MA10
3.67Buy
3.77Buy
MA20
3.05Buy
3.36Buy
MA50
2.91Buy
2.99Buy
MA100
2.71Buy
2.81Buy
MA200
2.58Buy
2.59Buy
NervGen Pharma’s (NGENF) 10-Day exponential moving average is 3.77, while NervGen Pharma’s (NGENF) share price is $4.15, making it a Buy.
NervGen Pharma’s (NGENF) 100-Day exponential moving average is 2.81, while NervGen Pharma’s (NGENF) share price is $4.15, making it a Buy.
NervGen Pharma’s (NGENF) stock price is $4.15 and NervGen Pharma’s (NGENF) 50-day simple moving average is 2.91, creating a Buy signal.
NervGen Pharma’s (NGENF) stock price is $4.15 and NervGen Pharma’s (NGENF) 100-day simple moving average is 2.71, creating a Buy signal.
NervGen Pharma’s (NGENF) stock price is $4.15 and NervGen Pharma’s (NGENF) 200-day simple moving average is 2.58, creating a Buy signal.

NervGen Pharma (NGENF) Technical Indicators

Dec 06, 2025, 02:11 AM
Name
Value
Implied Action
RSI (14)
69.74
Neutral
STOCH (9,6)
81.63
Sell
STOCHRSI (14)
82.64
Sell
MACD (12,26)
0.43
Sell
ADX (14)
42.85
Neutral
Williams %R
-23.01
Buy
CCI (14)
122.79
Sell
ATR (14)
0.37
-
Ultimate Oscillator
56.32
Neutral
ROC
69.39
Buy
NervGen Pharma’s (NGENF) Relative Strength Index (RSI) is 69.74, creating a Neutral signal.
NervGen Pharma’s (NGENF) Trend Strength Indicator (ADX) is 42.85, creating a Neutral signal.
NervGen Pharma’s (NGENF) Commodity Channel Index (CCI) is 122.79, creating a Sell signal.
NervGen Pharma’s (NGENF) Price Rate of Change (ROC) is 69.39, creating a Buy signal.

FAQ

Is NGENF a Buy, Hold, or Sell?
Based on NGENF’s technical indicators, NGENF is a Buy.
    What is NGENF’s RSI (14)?
    NGENF’s RSI (14) is 69.74, which suggests NGENF is a Neutral.
      What is NGENF’s MACD?
      NGENF’s MACD is 0.43, which suggests NGENF is a Sell.
        What is NGENF’s 5-day moving average?
        NGENF’s 5-day moving average is 4.24, which suggests NGENF is a Sell.
          What is NGENF’s 20-day moving average?
          NGENF 20-day moving average is 3.05, which suggests NGENF is a Buy.
            What is NGENF’s 50-day moving average?
            NGENF’s 50-day moving average is 2.91, which suggests NGENF is a Buy.
              What is NGENF’s 200-day moving average?
              NGENF’s 200-day moving average is 2.58, which suggests NGENF is a Buy.
                What is NGENF’s Williams % R (14)?
                NGENF’s Williams % R (14) is -23.01, which suggests NGENF is a Buy.
                  What is NGENF’s CCI (14)?
                  NGENF’s CCI (14) is 122.79, which suggests NGENF is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis